TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34372851

Group type: EXPERIMENTAL
Intervention: Nurse-coordinated transitional care intervention (Cardiac Care Bridge program)
Number of subjects: 16
Study: 34325975

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (200 mg continuous infusion for 7 days)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 405
Study: 33740568

Group type: EXPERIMENTAL
Intervention: IV ibuprofen 400 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: IV paracetamol 1000 mg
Number of subjects: 200
Study: 32457366

Group type: EXPERIMENTAL
Intervention: Water spray (WS) applied every 15 minutes during exercise
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control (C) without WS
Number of subjects: 27
Study: 34544170

Group type: EXPERIMENTAL
Intervention: Existing risk scores for bleeding in venous thromboembolism (ACCP‐VTE, HAS‐BLED, Hokusai, Kuijer, Martinez, RIETE, and VTE‐BLEED)
Number of subjects: 1046

Group type: EXPERIMENTAL
Intervention: Pragmatic classification based on cancer type (gastrointestinal; genitourinary; other)
Number of subjects: 1046

Group type: EXPERIMENTAL
Intervention: Newly derived competing risk‐adjusted prediction model (CAT‐BLEED)
Number of subjects: 1046
Study: 33755168

Group type: EXPERIMENTAL
Intervention: High-dose amoxicillin (875 mg) plus clavulanate (125 mg) twice a day for 7 days
Number of subjects: 157

Group type: COMPARATOR
Intervention: Standard-dose amoxicillin (875 mg) plus clavulanate (125 mg) plus placebo, twice a day for 7 days
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: High-dose amoxicillin (875 mg) plus clavulanate (125 mg)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Standard-dose amoxicillin (875 mg) plus clavulanate (125 mg) plus placebo
Number of subjects: 157
Study: 34256031

Group type: EXPERIMENTAL
Intervention: Tezepelumab 210 mg administered subcutaneously every 4 weeks for 28 weeks (extended to 52 weeks if needed)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Tezepelumab
Number of subjects: 250
Study: 32359153

Group type: EXPERIMENTAL
Intervention: USDA‐LB (150 g/d lean beef as an isocaloric replacement for carbohydrate)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: USDA‐LB
Number of subjects: 33

Group type: COMPARATOR
Intervention: USDA‐CON (USDA Healthy US‐Style Eating Pattern, low in saturated fat and red meat)
Number of subjects: 33

Group type: COMPARATOR
Intervention: USDA‐CON
Number of subjects: 33
Study: 35953719

Group type: EXPERIMENTAL
Intervention: Obicetrapib 5 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Obicetrapib 10 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33957895

Group type: EXPERIMENTAL
Intervention: Physically active learning (PAL) group
Number of subjects: 2084

Group type: EXPERIMENTAL
Intervention: Don't worry ‐ Be Happy (DWBH) group
Number of subjects: 2084

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2084
Study: 35577470

Group type: EXPERIMENTAL
Intervention: Managing Unusual Sensory Experiences (MUSE)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 80
Study: 34314666

Group type: EXPERIMENTAL
Intervention: Children's Sexual Health Education Program (CSHEP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study: 34718932

Group type: EXPERIMENTAL
Intervention: Transient AKI (Stage 1)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Persistent AKI (Stage 1)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Transient AKI (Stage 2/3)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Persistent AKI (Stage 2/3)
Number of subjects: 292

Group type: COMPARATOR
Intervention: No AKI
Number of subjects: 292
Study: 32151605

Group type: EXPERIMENTAL
Intervention: Non-suicidal self-injury (NSSI) disorder (DSM-5)
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Self-injurious behavior
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Impulsiveness and loneliness scores
Number of subjects: 505
Study: 34420064

Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 46

Group type: COMPARATOR
Intervention: Community weight management intervention (CWI)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: STOP-BANG screening tool
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Epworth Sleepiness Scale
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Berlin questionnaire
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Changes in papilloedema
Number of subjects: 46
Study: 33259454

Group type: EXPERIMENTAL
Intervention: 7 cmH2O positive end-expiratory pressure
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0 cmH2O positive end-expiratory pressure (control group)
Number of subjects: 60
Study: 32609084

Group type: EXPERIMENTAL
Intervention: Progesterone (400 mg vaginal suppositories, twice daily)
Number of subjects: 4153

Group type: COMPARATOR
Intervention: Placebo (matched vaginal suppositories)
Number of subjects: 4153

Group type: COMPARATOR
Intervention: Cost-effectiveness analysis of Progesterone vs Placebo
Number of subjects: 4153
Study: 35509855

Group type: EXPERIMENTAL
Intervention: Doctor‐patient‐affective disorder intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: Routine intervention (Control)
Number of subjects: 300
Study: 35291422

Group type: EXPERIMENTAL
Intervention: MRI examination based on the BPSO intelligent feature optimization algorithm
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional MRI examination
Number of subjects: 120
Study: 32051386

Group type: EXPERIMENTAL
Intervention: Post-DOAC hsCRP >0.100 mg/dL
Number of subjects: 2216

Group type: EXPERIMENTAL
Intervention: ORBIT-i score
Number of subjects: 2216
Study: 34574675

Group type: EXPERIMENTAL
Intervention: Stone pine (Pinus cembra) solid wood beds
Number of subjects: 15

Group type: COMPARATOR
Intervention: Chipboard beds (control)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Stone pine beds
Number of subjects: 15
Study: 33455419

Group type: EXPERIMENTAL
Intervention: Individualized intervention (OBS)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Conventional intervention (CON)
Number of subjects: 79
Study: 34212138

Group type: EXPERIMENTAL
Intervention: Intravenous and topical Tranexamic Acid (TXA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (normal saline with epinephrine 1:100,000)
Number of subjects: 0
Study: 33788216

Group type: EXPERIMENTAL
Intervention: Vitamin D status in winter (25(OH)D concentration 26.9 nmol/L)
Number of subjects: 1111

Group type: EXPERIMENTAL
Intervention: Vitamin D status in summer (25(OH)D concentration 43.4 nmol/L)
Number of subjects: 1111

Group type: EXPERIMENTAL
Intervention: Living at a latitude higher than 33°
Number of subjects: 1111

Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 1111

Group type: EXPERIMENTAL
Intervention: Serum 25(OH)D concentration in winter
Number of subjects: 1111
Study: 34979503

Group type: EXPERIMENTAL
Intervention: Boron-based gel containing 3% sodium pentaborate pentahydrate
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo gel with no chemical substance
Number of subjects: 257
Study: 33962577

Group type: EXPERIMENTAL
Intervention: DIVERT‐CARE self‐management support and education intervention
Number of subjects: 29
Study: 32232880

Group type: EXPERIMENTAL
Intervention: TBI mild
Number of subjects: 176871

Group type: EXPERIMENTAL
Intervention: TBI non-mild
Number of subjects: 176871

Group type: EXPERIMENTAL
Intervention: PTSD
Number of subjects: 176871

Group type: EXPERIMENTAL
Intervention: TBI mild with PTSD
Number of subjects: 176871

Group type: EXPERIMENTAL
Intervention: TBI non-mild with PTSD
Number of subjects: 176871

Group type: EXPERIMENTAL
Intervention: TBI mild without PTSD
Number of subjects: 176871

Group type: EXPERIMENTAL
Intervention: TBI non-mild without PTSD
Number of subjects: 176871
Study: 36109024

Group type: EXPERIMENTAL
Intervention: Spiritual healing in addition to usual care
Number of subjects: 28

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 28
Study: 33876334

Group type: EXPERIMENTAL
Intervention: Oxygen-supplemented A-TE CXL
Number of subjects: 44

Group type: COMPARATOR
Intervention: Room air conditions A-TE CXL
Number of subjects: 44
Study: 33318317

Group type: EXPERIMENTAL
Intervention: Mindful awareness practice
Number of subjects: 0
Study: 32962461

Group type: EXPERIMENTAL
Intervention: TempWatch
Number of subjects: 100
Study: 33892722

Group type: EXPERIMENTAL
Intervention: Inofolic (4 g myo‐inositol + 400 μg folic acid)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Folic acid (400 μg)
Number of subjects: 60
Study: 35645134

Group type: EXPERIMENTAL
Intervention: Music (group M, n=35)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (group C, n=35)
Number of subjects: 70
Study: 33827537

Group type: EXPERIMENTAL
Intervention: Same-day mobilization group (mobilized when hemodynamically stable within four hours after surgery)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Same-day mobilization group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Next-day mobilization group (mobilized first time in the morning of the first post-operative day)
Number of subjects: 80
Study: 35114340

Group type: EXPERIMENTAL
Intervention: Jawarish Falafili (JF) 10 gm/day for 90 days
Number of subjects: 74

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg/day for 90 days
Number of subjects: 74
Study: 35818296

Group type: EXPERIMENTAL
Intervention: oVRcome app (self-guided virtual reality exposure and cognitive behaviour therapy)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 126
Study: 33671071

Group type: EXPERIMENTAL
Intervention: Bacillus subtilis DE111
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35170627

Group type: EXPERIMENTAL
Intervention: Diet with 0.25% calcium anacardate
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Diet with 0.50% calcium anacardate
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Diet with 0.75% calcium anacardate
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Diet with 1.0% calcium anacardate
Number of subjects: 252

Group type: COMPARATOR
Intervention: Diet without growth promoter
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Diet with 0.1% growth promoter
Number of subjects: 252
Study: 36088415

Group type: EXPERIMENTAL
Intervention: Group A (A1 pulley disconnected at the middle)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group B (A1 pulley disconnected at the extreme radial side)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group C (A1 pulley excised)
Number of subjects: 60
Study: 35907838

Group type: EXPERIMENTAL
Intervention: Health education intervention sessions on diabetes management
Number of subjects: 136
Study: 33764122

Group type: EXPERIMENTAL
Intervention: Incentivized ratings (monetary rewards or pro-social cues)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Voluntary reviews
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High monetary rewards or pro-social cues as incentives
Number of subjects: 0
Study: 32380449

Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS (HF group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: 1 Hz rTMS (LF group)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sham rTMS (sham group)
Number of subjects: 45
Study: 34417781

Group type: EXPERIMENTAL
Intervention: Subconjunctival triamcinolone acetonide (n = 36)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (n = 36)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Combination treatment (n = 45)
Number of subjects: 163

Group type: COMPARATOR
Intervention: No additional treatment (control group, n = 46)
Number of subjects: 163
Study: 34632865

Group type: EXPERIMENTAL
Intervention: Virtual game training using the SeeMe virtual game system (12 sessions of 30 minutes bi-weekly)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 31
Study: 32844575

Group type: EXPERIMENTAL
Intervention: Intradialytic group laughter therapy (30-minute session once weekly for 8 weeks)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (no laughter therapy)
Number of subjects: 151
Study: 35893343

Group type: EXPERIMENTAL
Intervention: Double-layer running suture re-anastomosis (Group 1)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Interrupted suture re-anastomosis (Group 2)
Number of subjects: 36
Study: 32189678

Group type: EXPERIMENTAL
Intervention: Cold chain equipment (CCEs) assessment using WHO‐UNICEF Effective Vaccine Management (EVM) tool
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Passive containers
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Electrical vaccine storage equipment
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Passive container capacity
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Ice packs preparation and storage capacity
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Planned preventive maintenance (PPM) of CCEs
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Standard operating procedures for emergency event management
Number of subjects: 29
Study: 35526121

Group type: COMPARATOR
Intervention: Immediate-release (IR) risedronate taken fasted (group A)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 1 taken fasted (group B)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 2 taken fasted (group C)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 3 taken fasted (group D)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 4 taken fasted (group E)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 1 taken with food (group F)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 2 taken with food (group G)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 3 taken with food (group H)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Gastro-resistant (GR) formulation 4 taken with food (group I)
Number of subjects: 160
Study: 33292629

Group type: EXPERIMENTAL
Intervention: Interpersonal art psychotherapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Delayed treatment control
Number of subjects: 20
Study: 36142086

Group type: EXPERIMENTAL
Intervention: Play in an upright position (45 min, three times a week for 3 months)
Number of subjects: 30
Study: 34103042

Group type: EXPERIMENTAL
Intervention: Verbascum Thapsus
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 32769065

Group type: EXPERIMENTAL
Intervention: Foot reflexology massage for 15 minutes
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo or control (not specified)
Number of subjects: 120
Study: 35524415

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D, n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (group C, n = 30)
Number of subjects: 60
Study: 34554690

Group type: EXPERIMENTAL
Intervention: Kinesiotaping with the space correction technique (KSCT, n = 20)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Kinesiotaping with the muscle inhibition technique (KMIT, n = 24)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Home exercise program (control group, CG, n = 27)
Number of subjects: 71
Study: 34548089

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program for 8 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: No-exercise control period for 8 weeks
Number of subjects: 17
Study: 33740127

Group type: EXPERIMENTAL
Intervention: Differentiated education (intervention group)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard education (control group)
Number of subjects: 79
Study: 34463434

Group type: EXPERIMENTAL
Intervention: Voclosporin (23.7 mg twice daily)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Voclosporin
Number of subjects: 357
Study: 35202553

Group type: EXPERIMENTAL
Intervention: 400 mg STM
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 200 mg STM
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 35822278

Group type: EXPERIMENTAL
Intervention: PPM discharge education
Number of subjects: 116

Group type: COMPARATOR
Intervention: Traditional discharge education
Number of subjects: 116
Study: 33736601

Group type: EXPERIMENTAL
Intervention: Warm solution containing 30 ml 5% sodium bicarbonate solution and 15 ml reformulated simethicone emulsion
Number of subjects: 523

Group type: COMPARATOR
Intervention: 45 ml 40 °C lukewarm water
Number of subjects: 523
Study: 32549127

Group type: EXPERIMENTAL
Intervention: Soft tissue mobilization (STM) and static stretching
Number of subjects: 78

Group type: COMPARATOR
Intervention: Static stretching
Number of subjects: 78
Study: 33592607

Group type: EXPERIMENTAL
Intervention: Topical glucocorticoids (TGC)
Number of subjects: 25
Study: 33176415

Group type: EXPERIMENTAL
Intervention: Ultrasonic scaler with ozonated water (left quadrants)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ultrasonic scaler (right quadrants)
Number of subjects: 10
Study: 36075079

Group type: EXPERIMENTAL
Intervention: Weight-based enoxaparin dosing (0.5 mg/kg every 12 hours)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Fixed-dose enoxaparin (40 mg daily for BMI < 40; 40 mg every 12 hours for BMI ≥ 40)
Number of subjects: 146
Study: 34152270

Group type: EXPERIMENTAL
Intervention: Online Remote Behavioral Intervention for Tics (ORBIT)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 112
Study: 32709872

Group type: EXPERIMENTAL
Intervention: Chronic pain
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Chronic pain PGS
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Genetic correlation
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 1206

Group type: EXPERIMENTAL
Intervention: Nine shared functional connectivity (FCs)
Number of subjects: 1206
Study: 35490599

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg for 2 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 30
Study: 33346091

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiation therapy to the prostate bed (51 Gy in 15 fractions, 3.4 Gy per fraction)
Number of subjects: 64
Study: 35978361

Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block (FICB) administered by paramedics
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: FICB
Number of subjects: 1400
Study: 33455792

Group type: EXPERIMENTAL
Intervention: Enzyme-treated soybean meal (ESBM)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard soybean meal (SBM)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low content of CP (10%) with no soy protein
Number of subjects: 12
Study: 32689993

Group type: EXPERIMENTAL
Intervention: Educational intervention based on the Health Belief Model (HBM)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Usual educational programs of rural health center
Number of subjects: 160
Study: 33570699

Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (PSI)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional instrumented (CI)
Number of subjects: 120
Study: 34250911

Group type: EXPERIMENTAL
Intervention: Single Bond Universal Agent (Group A)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Seal & Protect Agent (Group B)
Number of subjects: 254
Study: 32393099

Group type: EXPERIMENTAL
Intervention: Buffered hypertonic saline nasal irrigation with budesonide respule
Number of subjects: 52

Group type: COMPARATOR
Intervention: Buffered hypertonic saline nasal irrigation with placebo respule
Number of subjects: 52
Study: 34148802

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided long-axis (LAX) femoral artery catheterization
Number of subjects: 90

Group type: COMPARATOR
Intervention: Ultrasound-guided short-axis (SAX) femoral artery catheterization
Number of subjects: 90
Study: 33567127

Group type: EXPERIMENTAL
Intervention: Marfan syndrome (MFS) cohort
Number of subjects: 406

Group type: COMPARATOR
Intervention: Reference population
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: MFS cohort
Number of subjects: 406
Study: 34799518

Group type: EXPERIMENTAL
Intervention: Self-facilitated groups without a discussion guide
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Self-facilitated groups with a one-page discussion guide
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Overall intervention (both groups)
Number of subjects: 25
Study: 32227625

Group type: EXPERIMENTAL
Intervention: Ioversol 320
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Ioversol 350
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Iopromide 370
Number of subjects: 270
Study: 33772349

Group type: EXPERIMENTAL
Intervention: Rapid Diagnostic Test (RDT)
Number of subjects: 3322

Group type: EXPERIMENTAL
Intervention: Microscopy
Number of subjects: 3322

Group type: EXPERIMENTAL
Intervention: Conventional diagnostic tools (RDT and microscopy)
Number of subjects: 3322
Study: 36377263

Group type: EXPERIMENTAL
Intervention: VR-based guided meditations
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standalone mobile app guided meditations
Number of subjects: 32
Study: 33397540

Group type: EXPERIMENTAL
Intervention: Voluntary assisted dying
Number of subjects: 164

Group type: COMPARATOR
Intervention: Long-term illness
Number of subjects: 164
Study: 35992128

Group type: EXPERIMENTAL
Intervention: Bayesian network model for predicting new-onset diabetes
Number of subjects: 15934

Group type: COMPARATOR
Intervention: Logistic regression model using the same three predictors
Number of subjects: 15934
Study: 32146318

Group type: EXPERIMENTAL
Intervention: Practicing discrete key pressing sequences with letter stimuli
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Practicing discrete key pressing sequences with meaningless stimuli
Number of subjects: 0
Study: 33815533

Group type: EXPERIMENTAL
Intervention: α-viniferin administered three times a day for ten days using a sterile cotton swab stick.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: α-viniferin
Number of subjects: 0
Study: 32150085

Group type: EXPERIMENTAL
Intervention: TCM acupoint application
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo acupoint application
Number of subjects: 200